Harvest Portfolios Group Inc. Boosts Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Harvest Portfolios Group Inc. increased its holdings in UnitedHealth Group by 10.3%, acquiring an additional 14,061 shares, bringing its total to 150,694 shares, valued at approximately $78.9 million.
• UnitedHealth Group's latest earnings report showed an EPS of $4.08, below the consensus estimate, despite a year-over-year revenue increase of 12.9% to $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, resulting in an annualized dividend of $8.84 and a dividend yield of 2.9%, with a payout ratio of 38.30%.

Harvest Portfolios Group Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.3% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 150,694 shares of the healthcare conglomerate's stock after acquiring an additional 14,061 shares during the period. UnitedHealth Group makes up approximately 2.3% of Harvest Portfolios Group Inc.'s holdings, making the stock its 5th biggest position. Harvest Portfolios Group Inc.'s holdings in UnitedHealth Group were worth $78,926,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group in the fourth quarter worth $41,000. Finally, Copia Wealth Management bought a new stake in UnitedHealth Group in the fourth quarter worth $42,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $305.26 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock's fifty day moving average is $288.34 and its two-hundred day moving average is $385.99. The firm has a market capitalization of $276.46 billion, a P/E ratio of 13.23, a price-to-earnings-growth ratio of 1.98 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company posted $6.80 EPS. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Robert W. Baird reiterated an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $365.38.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.